Male pattern baldness affects roughly half of all men by age 50 and up to 85% by age 70. ( 1 ) It is the most common form of hair loss in men, yet it remains widely misunderstood. The condition is not caused by stress, hats, or poor hygiene. It is a predictable, genetically driven process tied to how your hair follicles respond to a specific hormone. Understanding that process is the first step toward doing something about it.
What Causes Male Pattern Baldness
Male pattern baldness, clinically known as androgenetic alopecia, is caused by the interaction between genetic predisposition and androgens, specifically dihydrotestosterone (DHT). ( 2 ) DHT is derived from testosterone through the action of an enzyme called 5-alpha reductase. In men who are genetically susceptible, DHT binds to receptors in hair follicles on the scalp and causes them to miniaturize over time.
Miniaturization means the follicle progressively produces thinner, shorter hairs until it eventually stops producing hair altogether. ( 3 ) The follicles themselves do not die, at least not in the early stages, which is why treatment can be effective when started early. The susceptibility to DHT is inherited and can come from either side of the family, not just the maternal grandfather as the old myth suggests.
Men with low testosterone are not necessarily protected from hair loss. What matters is how sensitive the follicles are to DHT, not the absolute level of testosterone in the blood.
The Science: How Hair Loss Progresses
Hair growth follows a cycle: anagen (active growth), catagen (transition), and telogen (resting and shedding). In healthy follicles, the anagen phase lasts two to six years. In follicles affected by DHT, the anagen phase shortens with each cycle, and the telogen phase extends. ( 4 ) The result is that affected follicles spend more time dormant and less time growing.
Male pattern baldness follows a recognizable pattern described by the Norwood-Hamilton scale, which classifies hair loss into seven stages. ( 5 ) Stage I shows minimal recession. Stage II involves slight recession at the temples. By Stage III, recession is clearly visible. Stages IV through VII describe progressive loss across the crown and top of the scalp, eventually leaving only a horseshoe-shaped band of hair around the sides and back.
The hair on the sides and back of the head is genetically resistant to DHT, which is why it persists even in men with significant hair loss. This is also why follicles from those areas are used in hair transplant procedures.
Treatment Options
Several treatments are clinically validated for male pattern baldness. None of them reverse significant loss overnight, and their effectiveness depends on how early treatment begins.
Minoxidil
Minoxidil is a topical treatment applied directly to the scalp. It was originally developed as a blood pressure medication, and scalp hair growth was discovered as a side effect. ( 6 ) Clinical trials have shown it can slow hair loss and stimulate regrowth in men with androgenetic alopecia, particularly in the early stages. It requires consistent daily use; stopping treatment reverses any gains within months.
Finasteride
Finasteride works by inhibiting 5-alpha reductase, the enzyme that converts testosterone to DHT. By reducing DHT levels in the scalp, it slows follicle miniaturization and, in many men, promotes regrowth. In a landmark clinical trial published in the Journal of the American Academy of Dermatology, men taking finasteride showed statistically significant improvements in hair count compared to placebo over two years. ( 7 ) It is taken orally and requires a prescription.
Hair Transplants
Follicular Unit Extraction (FUE) and Follicular Unit Transplantation (FUT) are surgical options for men with established hair loss. Both methods involve harvesting DHT-resistant follicles from the back of the scalp and transplanting them to areas of thinning or baldness. Results are permanent, but the procedures are costly and require careful patient selection.
PRP Therapy
Platelet-rich plasma (PRP) therapy involves injecting concentrated growth factors derived from the patient’s own blood into the scalp. Research published in Dermatologic Surgery suggests PRP can increase hair density and thickness in men with androgenetic alopecia, though standardization of protocols remains an area of ongoing study. ( 8 )
Common Myths About Male Pattern Baldness
Myth: Wearing hats causes baldness. There is no scientific evidence that hat-wearing restricts blood flow enough to cause follicle miniaturization. Hats do not cause androgenetic alopecia.
Myth: Hair loss comes only from your mother’s side. The androgen receptor gene is located on the X chromosome, which men inherit from their mothers, but research confirms that hair loss susceptibility involves multiple genes from both parents. ( 9 )
Myth: Washing hair too often causes thinning. Shampooing does not accelerate follicle miniaturization. You may notice shed hairs in the shower, but washing does not cause the loss itself.
Myth: Bald men have higher testosterone. DHT sensitivity, not testosterone volume, drives hair loss. Some men with low testosterone still experience significant baldness.
When to See a Doctor
See a dermatologist or men’s health physician if you notice sudden or patchy hair loss, hair loss accompanied by scalp pain or itching, diffuse shedding across the entire scalp, or hair loss that begins before your mid-20s. These patterns can indicate conditions other than androgenetic alopecia, including alopecia areata, telogen effluvium, or thyroid dysfunction. ( 10 )
If your hair loss is gradual and follows the Norwood-Hamilton pattern, a physician can confirm the diagnosis and discuss your options for treatment. Early intervention typically yields better results than waiting until loss is advanced.
It is also worth reviewing your testosterone levels by age with your doctor, particularly if you are also experiencing symptoms like fatigue, low libido, or reduced muscle mass alongside hair thinning.
Take the Next Step
Male pattern baldness is manageable, especially when addressed early. If you are starting to notice recession or thinning, do not wait. Speak with a men’s health physician who can evaluate your pattern, rule out other causes, and walk you through evidence-based options that match your stage of loss and lifestyle. The treatments that work best are the ones you start soonest.
Emergency Notice: If you or someone else is experiencing a medical emergency, call 911 immediately. The information on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
References
- Norwood OT. Male pattern baldness: classification and incidence. Southern Medical Journal. 1975;68(11):1359–1365. https://doi.org/10.1097/00007611-197511000-00009
- Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE. Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science. 1974;186(4170):1213–1215. https://doi.org/10.1126/science.186.4170.1213
- Sinclair R. Male pattern androgenetic alopecia. BMJ. 1998;317(7162):865–869. https://doi.org/10.1136/bmj.317.7162.865
- Paus R, Cotsarelis G. The biology of hair follicles. New England Journal of Medicine. 1999;341(7):491–497. https://doi.org/10.1056/NEJM199908123410706
- Hamilton JB. Patterned loss of hair in man; types and incidence. Annals of the New York Academy of Sciences. 1951;53(3):708–728. https://doi.org/10.1111/j.1749-6632.1951.tb31971.x
- Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. British Journal of Dermatology. 2004;150(2):186–194. https://doi.org/10.1111/j.1365-2133.2004.05785.x
- Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. Journal of the American Academy of Dermatology. 1998;39(4):578–589. https://doi.org/10.1016/S0190-9622(98)70007-6
- Alves R, Grimalt R. Randomized placebo-controlled, double-blind, half-head study to assess the efficacy of platelet-rich plasma on the treatment of androgenetic alopecia. Dermatologic Surgery. 2016;42(4):491–497. https://doi.org/10.1097/DSS.0000000000000665
- Hillmer AM, Hanneken S, Ritzmann S, et al. Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. American Journal of Human Genetics. 2005;77(1):140–148. https://doi.org/10.1086/431425
- Alkhalifah A. Alopecia areata update. Dermatologic Clinics. 2013;31(1):93–108. https://doi.org/10.1016/j.det.2012.08.010